Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00110552
Status:
COMPLETED
Last Update Posted:
2014-10-29
First Post:
2005-05-10
Brief Title:
Effects of Sage on Memory and Mental Performance in Alzheimers Disease Patients
Sponsor:
Oregon Health and Science University
Organization:
Oregon Health and Science University
Study Overview
Official Title:
Effects of a Cognitive Enhancer on Memory and Cognitive Performance
Status:
COMPLETED
Status Verified Date:
2014-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the effectiveness of the herb sage in improving the mental function of individuals with Alzheimers disease
Study hypothesis The administration of sage will improve cognitive function in patients with mild Alzheimers disease
Study hypothesis The administration of sage will improve cognitive function in patients with mild Alzheimers disease
Detailed Description:
The herb sage has been shown to enhance memory and mental function in healthy young adults However studies assessing the herbs effectiveness in older adults with symptoms of Alzheimers disease are limited This study will determine the effect of sage extract on the cognitive function of patients with mild Alzheimers disease
This study will last 6 weeks and will comprise 4 study visits approximately 10 days apart Participants will be randomly assigned to receive either sage pills or no treatment during each 10-day period The treatment assignments will be switched in 10-day intervals so that during the course of the study each participant will undergo two periods of sage treatment and two periods without treatment At each study visit participants will undergo cognitive testing including tests to determine attention memory and visual cognition Participants will also undergo an electroencephalogram EEG and an electrocardiogram ECG at each visit
This study will last 6 weeks and will comprise 4 study visits approximately 10 days apart Participants will be randomly assigned to receive either sage pills or no treatment during each 10-day period The treatment assignments will be switched in 10-day intervals so that during the course of the study each participant will undergo two periods of sage treatment and two periods without treatment At each study visit participants will undergo cognitive testing including tests to determine attention memory and visual cognition Participants will also undergo an electroencephalogram EEG and an electrocardiogram ECG at each visit
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U19AT002656-03 | NIH | None | httpsreporternihgovquickSearchU19AT002656-03 |